News
Canada approves Ozempic to reduce risk of diabetic kidney disease progression
Canada's health regulator has approved Novo Nordisk's diabetes drug, Ozempic, for reducing the risk of kidney failure and disease progression, as well as death due to heart problems in diabetes patients with chronic kidney disease,
Cheaper versions of medications to treat obesity, like Ozempic and Wegovy, could be on the market in Canada as soon as January.
With shortages of Ozempic at U.S. pharmacies, some Americans have been turning to Canada and Mexico to buy the medication, a Type 2 diabetes treatment many people are using off-label to lose ...
Canada is cracking down on Americans who send their Ozempic prescriptions to Canada to save money. On Tuesday, British Columbia Minister of Health Adrian Dix announced that his province will be ...
2:02 B.C. to limit sales of Ozempic to non-Canadians Canada’s pharmacists worry a lack of data about prescription management could see a repeat of the situation with diabetes and weight-loss ...
Ozempic ® demonstrated clinically meaningful improvements in blood sugar and body weight vs comparators 1 MISSISSAUGA, ON, Jan. 9, 2018 /CNW/ - Novo Nordisk announced today that Health Canada has ...
Novo Nordisk said on Monday it was offering its diabetes drug Ozempic for $499 per month to eligible cash-paying patients ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback